Results 241 to 250 of about 93,801 (340)

Why, When, and How to Treat Dynamic Forehead Lines with Botulinum Toxin Type A. [PDF]

open access: yesToxins (Basel)
de Sanctis Pecora C   +3 more
europepmc   +1 more source

Innovative Drug Delivery Systems for the Treatment of Glaucoma

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu   +9 more
wiley   +1 more source

Laurels or Thorns of Trust? How Embeddedness Moderates the Exchange‐Satisfaction Relationship in Franchising

open access: yesManagerial and Decision Economics, Volume 47, Issue 4, Page 863-879, June 2026.
ABSTRACT Exchanges in franchise systems are embedded in the level of trust that exists in franchisee–franchisor relationships. Although trust is essential in business relationships, it can unfold a negative side effect on the appreciation of exchange in these relationships as hidden costs of trust.
Matthias Glaser   +2 more
wiley   +1 more source

Development and Validation of a Deep Learning‐Based Facial Weakness Score for Objective Assessment in Facioscapulohumeral Muscular Dystrophy

open access: yesMuscle &Nerve, Volume 73, Issue 6, Page 1096-1102, June 2026.
ABSTRACT Introduction/Aims Facioscapulohumeral muscular dystrophy (FSHD) is a muscle disease that leads, among other manifestations, to facial weakness. This weakness can severely impact communication and quality of life, yet it remains under‐researched with limited objective clinical measures.
T. G. J. Loonen   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy